The influence of Ouabain on human dendritic cells maturation

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Nascimento, C R ^a   Valente, R C ^a   Echevarria Lima, J ^a   Fontes, C F L ^a   De Araujo Martins, L ^b   Araujo, E G ^b   Rumjanek, V M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CD83 ANTIGEN; GLUCOCORTICOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 4; OUABAIN; TUMOR NECROSIS FACTOR ALPHA; CD14 ANTIGEN; CD86 ANTIGEN; CYTOKINE; ENZYME INHIBITOR; FC RECEPTOR; HLA DR ANTIGEN; IL4 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CELL VIABILITY ASSAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FUNCTIONAL STATUS; GENE EXPRESSION; HELPER CELL; HUMAN; HUMAN CELL; HYDROLYSIS; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IN VITRO STUDY; LIQUID SCINTILLATION COUNTING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MICROSOME; MIXED LYMPHOCYTE REACTION; MONOCYTE; MTT ASSAY; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; THYMOCYTE; UPREGULATION; WESTERN BLOTTING; CELL LINEAGE; CELL MEMBRANE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE; METABOLISM;

STROPHANTHUS GRATUS;

ANTIGENS, CD14; ANTIGENS, CD86; CELL DIFFERENTIATION; CELL LINEAGE; CELL MEMBRANE; CELL PROLIFERATION; CYTOKINES; DENDRITIC CELLS; ENDOCYTOSIS; ENZYME INHIBITORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HLA-DR ANTIGENS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-4; LYMPHOCYTES; NF-KAPPA B; OUABAIN; PHENOTYPE; RECEPTORS, IGG; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84921280997     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/494956     Document Type: Article

References (51)

1. J. Banchereau and R. M. Steinman, "Dendritic cells and the control of immunity," Nature, vol. 392, no. 6673, pp. 245-252, 1998.
2. S. H. Naik, "Demystifying the development of dendritic cell subtypes, a little," Immunology and Cell Biology, vol. 86, no. 5, pp. 439-452, 2008.
3. R. M. Steinman, D. Hawiger, and M. C. Nussenzweig, "Tolerogenic dendritic cells," Annual Review of Immunology, vol. 21, pp. 685-711, 2003.
4. M. Naranjo-Gómez, D. Räch-Regué, C. Oñate et al., "Comparative study of clinical grade human tolerogenic dendritic cells," Journal of Translational Medicine, vol. 9, article 89, 2011.
5. A. Mancino, T. Schioppa, P. Larghi et al., "Divergent effects of hypoxia on dendritic cell functions," Blood, vol. 112, no. 9, pp. 3723-3734, 2008.
6. C. R. Nascimento, C. G. Freire-de-Lima, A. da Silva de Oliveira, F. D. Rumjanek, andV. M. Rumjanek, "The short chain fatty acid sodium butyrate regulates the induction of CD1a in developing dendritic cells," Immunobiology, vol. 216, no. 3, pp. 275-284, 2011.
7. P. Matzinger, "Tolerance, danger, and the extended family," Annual Review of Immunology, vol. 12, pp. 991-1045, 1994.
8. P. Guermonprez, J. Valladeau, L. Zitvogel, C. Théry, and S. Amigorena, "Antigen presentation and T cell stimulation by dendritic cells," Annual Review of Immunology, vol. 20, pp. 621-667, 2002.
9. K. O. Haustein, "Digitalis," Pharmacology andTherapeutics, vol. 18, no. 1, pp. 1-89, 1982.
10. R. C. Valente, C. R. Nascimento, E. G. Araujo, and V. M. Rumjanek, "mCD14 expression in human monocytes is downregulated by ouabain via transactivation of epithelial growth factor receptor and activation of p38 mitogen-activated protein kinase," NeuroImmunoModulation, vol. 16, no. 4, pp. 228-236, 2009.
11. R. C. Valente, E. G. Araujo, andV. M. Rumjanek, "Ouabain inhibits monocyte activation in vitro: prevention of the proinflammatory mCD14+/CD16+ subset appearance and cell-size progression," Journal of Experimental Pharmacology, vol. 4, pp. 125-140, 2012.
12. S. Rodrigues-Mascarenhas, A. D. S. De Oliveira, N. D. Amoedo, O. R. Affonso-Mitidieri, F. D. Rumjanek, and V. M. Rumjanek, "Modulation of the immune system by ouabain," Annals of the New York Academy of Sciences, vol. 1153, pp. 153-163, 2009.
13. A. Matsumori, K. Ono, R. Nishio et al., "Modulation of cytokine production and protection against lethal endotoxemia by the cardiac glycoside ouabain," Circulation, vol. 96, no. 5, pp. 1501-1506, 1997.
14. A. D. Foey, A. Crawford, and N. D. Hall, "Modulation of cytokine production by humanmononuclear cells following impairment of Na,K-ATPase activity," Biochimica et Biophysica Acta: Molecular Cell Research, vol. 1355, no. 1, pp. 43-49, 1997.
15. M. P. Teixeira and V. M. Rumjanek, "Ouabain affects the expression of activationmarkers, cytokine production, and endocytosis of human monocytes," Mediators of Inflammation, vol. 2014, Article ID 760368, 10 pages, 2014.
16. D. I. B. de Vasconcelos, J. A. Leite, L. T. Carneiro et al., "Antiinflammatory and antinociceptive activity of Ouabain in mice," Mediators of Inflammation, vol. 2011, Article ID912925, 11 pages, 2011.
17. P. L. Jacob, J. A. Leite, A. K. A. Alves et al., "Immunomodulatory activity of ouabain in Leishmania leishmania amazonensisinfected Swiss mice," Parasitology Research, vol. 112, no. 3, pp. 1313-1321, 2013.
18. C. F. Goncalves-De-Albuquerque, P. Burth, A. R. Silva et al., "Oleic acid inhibits lung Na/K-ATPase in mice and induces injury with lipid body formation in leukocytes and eicosanoid production," Journal of Inflammation, vol. 10, no. 1, article 34, 2013.
19. J. M. Hamlyn, M. P. Blaustein, S. Bova et al., "Identification and characterization of a ouabain-like compound from human plasma," Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 14, pp. 6259-6263, 1991.
20. W. Schoner, N. Bauer, J. Müller-Ehmsen et al., "Ouabain as a mammalian hormone," Annals of the New York Academy of Sciences, vol. 986, pp. 678-684, 2003.
21. O. Vakkuri, S. S. Árnason, A. Pouta, O. Vuolteenaho, and J. Leppäluoto, "Radioimmunoassay of plasma ouabain in healthy and pregnant individuals," Journal of Endocrinology, vol. 165, no. 3, pp. 669-677, 2000.
22. J. M. Hamlyn, B. P. Hamilton, and P. Manunta, "Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis," Journal of Hypertension, vol. 14, no. 2, pp. 151-167, 1996.
23. R. G. Contreras, L. Shoshani, C. Flores-Maldonado, A. Lázaro, and M. Cereijido, "Relationship between Na+,K+-ATPase and cell attachment," Journal of Cell Science, vol. 112, no. 23, pp. 4223-4232, 1999.
24. J. Liu, J. Tian, M. Haas, J. I. Shapiro, A. Askari, and Z. Xie, "Ouabain interaction with cardiac Na+/K+-ATPase initiates signal cascades independent of changes in intracellularNa+ and Ca2+ concentrations,"The Journal of Biological Chemistry, vol. 275, no. 36, pp. 27838-27844, 2000.
25. G. de Rezende Correa, A. Araujo dos Santos, C. F. Leite Fontes, and E. Giestal De Araujo, "Ouabain induces an increase of retinal ganglion cell survival in vitro: the involvement of protein kinase C," Brain Research, vol. 1049, no. 1, pp. 89-94, 2005.
26. M. Li, Q. Wang, and L. Guan, "Effects of ouabain on proliferation, intracellular free calcium and c-myc mRNA expression in vascular smooth muscle cells," Journal of Comparative Physiology B: Biochemical, Systemic, andEnvironmentalPhysiology, vol. 177, no. 5, pp. 589-595, 2007.
27. M. M. Bradford, "A rapid and sensitive method for the quantitation ofmicrogramquantities of protein utilizing the principle of protein dye binding," Analytical Biochemistry, vol. 72, no. 1-2, pp. 248-254, 1976.
28. C. L. Mann, C. D. Bortner, C. M. Jewell, and J. A. Cidlowski, "Glucocorticoid-induced plasma membrane depolarization during thymocyte apoptosis: association with cell shrinkage and degradation of theNA(+)/K(+)-adenosine triphosphatase," Endocrinology, vol. 141, no. 12, pp. 5059-5068, 2001.
29. T. F. Walseth and R. A. Johnson, "The enzymatic preparation of [-32P]nucleoside triphosphates, cyclic [32P]AMP, and cyclic
30. GMP," Biochimica et Biophysica Acta (BBA)-Nucleic Acids and Protein Synthesis, vol. 562, no. 1, pp. 11-31, 1979.
31. J. C. C. Maia, S. L. Gomes, M. H. Juliani, and C. M. Morel, Eds., Genes and Antiges of Parasites-A LaboratoryManual Proceedings, FIOCRUZ, Rio de Janeiro, Brazil, 1988.
32. C. F. L. Fontes, F. E. V. Lopes, H. M. Scofano, H. Barrabin, and J. G. Nørby, "Stimulation of ouabain binding to Na,KATPase in 40% dimethyl sulfoxide by a factor from Na,KATPase preparations," Archives of Biochemistry and Biophysics, vol. 366, no. 2, pp. 215-223, 1999.
33. C. Grubmeyer and H. S. Penefsky, "The presence of two hydrolytic sites on beef heart mitochondrial adenosine triphosphatase," Journal of Biological Chemistry, vol. 256, no. 8, pp. 3718-3727, 1981.
34. F. Sallusto and A. Lanzavecchia, "Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor ," The Journal of Experimental Medicine, vol. 179, no. 4, pp. 1109-1118, 1994.
35. J. M. Motta, C. R. Nascimento, and V. M. Rumjanek, "Leukemic cell products down-regulate human dendritic cell differentiation," Cancer Immunology, Immunotherapy, vol. 59, no. 11, pp. 1645-1653, 2010.
36. Z. Xie, "Molecular mechanisms of Na/K-ATPase-mediated signal transduction," Annals of the New York Academy of Sciences, vol. 986, pp. 497-503, 2003.
37. J.-F. Arrighi, M. Rebsamen, F. Rousset, V. Kindler, and C. Hauser, "A critical role for p38mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-, and contact sensitizers," The Journal of Immunology, vol. 166, no. 6, pp. 3837-3845, 2001.
38. J. Banchereau, F. Briere, C. Caux et al., "Immunobiology of dendritic cells," Annual Review of Immunology, vol. 18, pp. 767-811, 2000.
39. V. K. Kuchroo, M. Prabhu Das, J. A. Brown et al., "B7-1 and B7-2 costimulatorymolecules activate differentially theTh1/Th2 developmental pathways: Application to autoimmune disease therapy," Cell, vol. 80, no. 5, pp. 707-718, 1995.
40. S. S. Diebold, "Determination of T-cell fate by dendritic cells," Immunology & Cell Biology, vol. 86, no. 5, pp. 389-397, 2008.
41. M. D. Säemann, G. A. Böhmig, C. H. Osterreicher et al., "Antiinflammatory effects of sodium butyrate on humanmonocytes: potent inhibition of IL-12 and up-regulation of IL-10 production," The FASEB Journal, vol. 14, no. 15, pp. 2380-2382, 2000.
42. A. G. Therien and R. Blostein, "Mechanisms of sodium pump regulation," The American Journal of Physiology-Cell Physiology, vol. 279, no. 3, pp. C541-C566, 2000.
43. R. G. Contreras, A. Lázaro, A. Mújica et al., "Ouabain resistance of the epithelial cell line (Ma104) is not due to lack of affinity of its pumps for the drug," The Journal of Membrane Biology, vol. 145, no. 3, pp. 295-303, 1995.
44. A. Wikman, A. Fagergren, S. G. O. Johansson, J. Lundahl, and S. H. Jacobson, "Monocyte activation and relationship to anti-proteinase 3 in acute vasculitis," Nephrology Dialysis Transplantation, vol. 18, no. 9, pp. 1792-1799, 2003.
45. K. A. Armah, K. McGinnis, J. Baker et al., "HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation," Clinical Infectious Diseases, vol. 55, no. 1, pp. 126-136, 2012.
46. C.-C. J. Chang, A. Wright, and J. Punnonen, "Monocyte-derived CD1a+ and CD1a dendritic cell subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation," The Journal of Immunology, vol. 165, no. 7, pp. 3584-3591, 2000.
47. M. Schnurr, F. Then, P. Galambos et al., "Extracellular ATP and TNF- synergize in the activation and maturation of human dendritic cells," The Journal of Immunology, vol. 165, no. 8, pp. 4704-4709, 2000.
48. M. Y. Jung, H.-S. Kim, H.-J. Hong, B.-S. Youn, and T. S. Kim, "Adiponectin induces dendritic cell activation via PLCgamma/JNK/NF-kappaB pathways, leading to Th1 and Th17 polarization," The Journal of Immunology, vol. 188, no. 6, pp. 2592-2601, 2012.
49. K. M. Ardeshna, A. R. Pizzey, S. Devereux, and A. Khwaja, "The PI3 kinase, p38 SAP kinase, andNF-b signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells," Blood, vol. 96, no. 3, pp. 1039-1046, 2000.
50. H. Häcker, H. Mischak, T. Miethke et al., "CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation," The EMBO Journal, vol. 17, no. 21, pp. 6230-6240, 1998.
51. E. Zsiros, K. Kis-Toth, P. Hajdu et al., "Developmental switch of the expression of ion channels in human dendritic cells," Journal of Immunology, vol. 183, no. 7, pp. 4483-4492, 2009.